ArticleScience advances2026
Ionic liquid-regulated interfacial charge transport and asymmetric device architecture for high-performance electrochemiluminescence.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrochemiluminescence (ECL) devices are promising alternatives to organic light-emitting diodes (OLEDs) and light-emitting capacitors (LECs) due to their simple structure and lower operating voltage, yet realizing sufficient luminance for practical applications remains challenging. Here, we report a synergistic material-device strategy for ultrabright electrochemiluminescent (UBECL) devices. Decoupling anion and cation effects reveals ion-dependent control of interfacial charge-transfer dynamics and electrochemical stability in annihilation-ECL. An effective electrolyte with favorable photophysical and electrochemical properties, coupled with an asymmetric device architecture, enhances electrochemical reactivity and maximizes ECL brightness. UBECL device turns on at a low alternating voltage (±1.65 V) and operates under high-frequency driving. It achieves a maximum luminance of 1552 cd m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.